205 related articles for article (PubMed ID: 23633922)
1. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
Moreno-Smith M; Lee SJ; Lu C; Nagaraja AS; He G; Rupaimoole R; Han HD; Jennings NB; Roh JW; Nishimura M; Kang Y; Allen JK; Armaiz GN; Matsuo K; Shahzad MM; Bottsford-Miller J; Langley RR; Cole SW; Lutgendorf SK; Siddik ZH; Sood AK
Neoplasia; 2013 May; 15(5):502-10. PubMed ID: 23633922
[TBL] [Abstract][Full Text] [Related]
2. Dopamine blocks stress-mediated ovarian carcinoma growth.
Moreno-Smith M; Lu C; Shahzad MM; Pena GN; Allen JK; Stone RL; Mangala LS; Han HD; Kim HS; Farley D; Berestein GL; Cole SW; Lutgendorf SK; Sood AK
Clin Cancer Res; 2011 Jun; 17(11):3649-59. PubMed ID: 21531818
[TBL] [Abstract][Full Text] [Related]
3. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Lu C; Shahzad MM; Moreno-Smith M; Lin YG; Jennings NB; Allen JK; Landen CN; Mangala LS; Armaiz-Pena GN; Schmandt R; Nick AM; Stone RL; Jaffe RB; Coleman RL; Sood AK
Cancer Biol Ther; 2010 Feb; 9(3):176-82. PubMed ID: 20009575
[TBL] [Abstract][Full Text] [Related]
4. Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer.
Merritt WM; Nick AM; Carroll AR; Lu C; Matsuo K; Dumble M; Jennings N; Zhang S; Lin YG; Spannuth WA; Kamat AA; Stone RL; Shahzad MM; Coleman RL; Kumar R; Sood AK
Mol Cancer Ther; 2010 Apr; 9(4):985-95. PubMed ID: 20371710
[TBL] [Abstract][Full Text] [Related]
5. Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.
Qin T; Wang C; Chen X; Duan C; Zhang X; Zhang J; Chai H; Tang T; Chen H; Yue J; Li Y; Yang J
Toxicol Appl Pharmacol; 2015 Jul; 286(2):112-23. PubMed ID: 25818600
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
Lu C; Kamat AA; Lin YG; Merritt WM; Landen CN; Kim TJ; Spannuth W; Arumugam T; Han LY; Jennings NB; Logsdon C; Jaffe RB; Coleman RL; Sood AK
Clin Cancer Res; 2007 Jul; 13(14):4209-17. PubMed ID: 17634550
[TBL] [Abstract][Full Text] [Related]
7. Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
Lu C; Thaker PH; Lin YG; Spannuth W; Landen CN; Merritt WM; Jennings NB; Langley RR; Gershenson DM; Yancopoulos GD; Ellis LM; Jaffe RB; Coleman RL; Sood AK
Am J Obstet Gynecol; 2008 Apr; 198(4):477.e1-9; discussion 477.e9-10. PubMed ID: 18395047
[TBL] [Abstract][Full Text] [Related]
8. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
[TBL] [Abstract][Full Text] [Related]
9. Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.
Chakroborty D; Sarkar C; Yu H; Wang J; Liu Z; Dasgupta PS; Basu S
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20730-5. PubMed ID: 22143796
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.
Sinha S; Pal K; Elkhanany A; Dutta S; Cao Y; Mondal G; Iyer S; Somasundaram V; Couch FJ; Shridhar V; Bhattacharya R; Mukhopadhyay D; Srinivas P
Int J Cancer; 2013 Mar; 132(5):1201-12. PubMed ID: 22806981
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
Rosanò L; Spinella F; Salani D; Di Castro V; Venuti A; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2003 May; 63(10):2447-53. PubMed ID: 12750265
[TBL] [Abstract][Full Text] [Related]
13. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
Merritt WM; Lin YG; Spannuth WA; Fletcher MS; Kamat AA; Han LY; Landen CN; Jennings N; De Geest K; Langley RR; Villares G; Sanguino A; Lutgendorf SK; Lopez-Berestein G; Bar-Eli MM; Sood AK
J Natl Cancer Inst; 2008 Mar; 100(5):359-72. PubMed ID: 18314475
[TBL] [Abstract][Full Text] [Related]
15. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
Arjaans M; Oude Munnink TH; Oosting SF; Terwisscha van Scheltinga AG; Gietema JA; Garbacik ET; Timmer-Bosscha H; Lub-de Hooge MN; Schröder CP; de Vries EG
Cancer Res; 2013 Jun; 73(11):3347-55. PubMed ID: 23580572
[TBL] [Abstract][Full Text] [Related]
17. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
18. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
[TBL] [Abstract][Full Text] [Related]
19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
20. Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.
Sarkar C; Chakroborty D; Dasgupta PS; Basu S
Int J Cancer; 2015 Aug; 137(3):744-9. PubMed ID: 25556636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
